Literature DB >> 17361347

Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange.

Shohei Watanabe, Ichiro Nakashima, Isabelle Miyazawa, Tatsuro Misu, Yusei Shiga, Yoichi Nakagawa, Kazuo Fujihara, Yasuto Itoyama.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17361347     DOI: 10.1007/s00415-006-0329-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

Review 1.  Plasma exchange for severe optic neuritis: treatment of 10 patients.

Authors:  K Ruprecht; E Klinker; T Dintelmann; P Rieckmann; R Gold
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

2.  A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

Authors:  B G Weinshenker; P C O'Brien; T M Petterson; J H Noseworthy; C F Lucchinetti; D W Dodick; A A Pineda; L N Stevens; M Rodriguez
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

3.  [Anatomo-clinical study of Devic's optic neuromyelitis, of artificially prolonged development. Terminal septic encephalitis].

Authors:  M Tommasi; J Lecuire; A Masquin; J J Buffat
Journal:  Rev Neurol (Paris)       Date:  1966-05       Impact factor: 2.607

4.  Plasma exchange for severe attacks of CNS demyelination: predictors of response.

Authors:  M Keegan; A A Pineda; R L McClelland; C H Darby; M Rodriguez; B G Weinshenker
Journal:  Neurology       Date:  2002-01-08       Impact factor: 9.910

Review 5.  Neuromyelitis optica with hypothalamic involvement.

Authors:  Alexandre Y Poppe; Yves Lapierre; Denis Melançon; Diane Lowden; Lucy Wardell; Louise M Fullerton; Amit Bar-Or
Journal:  Mult Scler       Date:  2005-10       Impact factor: 6.312

6.  An open label study of the effects of rituximab in neuromyelitis optica.

Authors:  B A C Cree; S Lamb; K Morgan; A Chen; E Waubant; C Genain
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

7.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

8.  Recurrent optic neuromyelitis with endocrinopathies: a new syndrome.

Authors:  J C Vernant; P Cabre; D Smadja; H Merle; I Caubarrère; J Mikol; C M Poser
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

9.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Raul N Mandler; Dorian McGavern; Wolfgang Bruck; Gerald Gleich; Richard M Ransohoff; Corinna Trebst; Brian Weinshenker; Dean Wingerchuk; Joseph E Parisi; Hans Lassmann
Journal:  Brain       Date:  2002-07       Impact factor: 13.501

  9 in total
  5 in total

1.  Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study.

Authors:  M Nakamura; I Miyazawa; K Fujihara; I Nakashima; T Misu; S Watanabe; T Takahashi; Y Itoyama
Journal:  J Neurol       Date:  2008-02-04       Impact factor: 4.849

2.  Syndrome of inappropriate antidiuretic hormone secretion in patients with aquaporin-4 antibody.

Authors:  Shuxiang Pu; Youming Long; Ning Yang; Yihua He; Fulan Shan; Yongxiang Fan; Jianrui Yin; Qingchun Gao; Gao Cong
Journal:  J Neurol       Date:  2014-10-15       Impact factor: 4.849

3.  Beneficial plasma exchange response in central nervous system inflammatory demyelination.

Authors:  Setty M Magaña; B Mark Keegan; Brian G Weinshenker; Bradley J Erickson; Sean J Pittock; Vanda A Lennon; Moses Rodriguez; Kristine Thomsen; Stephen Weigand; Jay Mandrekar; Linda Linbo; Claudia F Lucchinetti
Journal:  Arch Neurol       Date:  2011-03-14

Review 4.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

5.  Plasma exchange in severe attacks of neuromyelitis optica.

Authors:  Mickael Bonnan; Philippe Cabre
Journal:  Mult Scler Int       Date:  2012-02-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.